BioSpace News Archive

Konica Minolta Precision Medicine, Inc. ( KMPM ) announced today a five-year collaboration with Amazon Web Services, Inc. (AWS). As the Preferred Cloud Provider for KMPM, AWS will support the build-out of the company’s LATTICE™ initiative globally.

Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA ® (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now reimbursed through the Newfoundland and Labrador Prescription Drug Program (NLPDP) under Special Authorization.

Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX / NASDAQ: RNLX), announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021 and ranked first in the Joint Ventures category.

Chimeron Bio, an RNA company pioneering a novel class of mRNA-based vaccines and therapeutics, is pleased to announce the appointment of Dr. Juan José Daboub and Dr. Wilmot James to its Accessible Medicines Advisory Board (AMAB).

This first in its class technology allows those experiencing chronic pain to undergo diagnostic imaging without the removal of the implant, featuring rechargeable or three-year non-rechargeable battery options.

Mr. Hayes has been active in the life science industry for more than 20 years with experience in technology transfer, venture capital, and finance.

- Enrollment of the first patient is expected in Q2 2021 - Trial will focus on patients without liver metastases, based on encouraging data in Phase Ib/II study - Trial targets indications where clinical outcomes can be improved versus standard therapeutic options and immune checkpoint inhibitors (“ICIs”) - Continued clinical collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to conduct the expanded Phase II study

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

The Academy of General Dentistry has named Colleen Lawler, CAE, IOM, as its new executive director.

Unlearn®, developer of the first machine-learning platform that creates Digital Twins used to enable smaller, faster clinical trials, today announced the appointment of Ann E. Taylor, M.D. to the company’s Board of Directors.